Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

551 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory Study.
van Lith SAM, Pruis IJ, Tolboom N, Snijders TJ, Henssen D, Ter Laan M, Te Dorsthorst M, Leenders WPJ, Gotthardt M, Nagarajah J, Robe PA, De Witt Hamer P, Hendrikse H, Oprea-Lager DE, Yaqub M, Boellaard R, Wesseling P, Balvers RK, Verburg FA, Harteveld AA, Smits M, van den Bent M, van Zanten SEMV, van de Giessen E. van Lith SAM, et al. Among authors: van den bent m, van zanten semv, van de giessen e. J Nucl Med. 2023 Oct;64(10):1526-1531. doi: 10.2967/jnumed.123.265738. Epub 2023 Aug 31. J Nucl Med. 2023. PMID: 37652540 Free article.
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.
Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, de Groot J, Koh ES, Law I, Le Rhun E, Mair MJ, Minniti G, Rudà R, Scott AM, Short SC, Smits M, Suchorska B, Tolboom N, Traub-Weidinger T, Tonn JC, Verger A, Weller M, Wen PY, Preusser M. Albert NL, et al. Among authors: van den bent mj. Lancet Oncol. 2024 Jan;25(1):e29-e41. doi: 10.1016/S1470-2045(23)00525-9. Lancet Oncol. 2024. PMID: 38181810 Review.
Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging study.
Pruis IJ, van Doormaal PJ, Balvers RK, van den Bent MJ, Harteveld AA, de Jong LC, Konijnenberg MW, Segbers M, Valkema R, Verburg FA, Smits M, Veldhuijzen van Zanten SEM. Pruis IJ, et al. Among authors: van doormaal pj, van den bent mj. EBioMedicine. 2024 Apr;102:105068. doi: 10.1016/j.ebiom.2024.105068. Epub 2024 Mar 22. EBioMedicine. 2024. PMID: 38518652 Free PMC article. Clinical Trial.
Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma: Longitudinal evidence of cognitive awareness from EORTC brain tumour trials.
Caramanna I, Reijneveld JC, van de Ven PM, van den Bent M, Idbaih A, Wick W, Taphoorn MJB, Dirven L, Bottomley A, Klein M; EORTC Quality of Life Group and EORTC Brain Tumor Group. Caramanna I, et al. Among authors: van den bent m, van de ven pm. Eur J Cancer. 2023 Jun;186:38-51. doi: 10.1016/j.ejca.2023.02.029. Epub 2023 Mar 8. Eur J Cancer. 2023. PMID: 37028200
ESTRO-EANO guideline on target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma.
Baumert BG, P M Jaspers J, Keil VC, Galldiks N, Izycka-Swieszewska E, Timmermann B, Grosu AL, Minniti G, Ricardi U, Dhermain F, Weber DC, van den Bent M, Rudà R, Niyazi M, Erridge S. Baumert BG, et al. Among authors: van den bent m. Radiother Oncol. 2025 Jan;202:110594. doi: 10.1016/j.radonc.2024.110594. Epub 2024 Oct 24. Radiother Oncol. 2025. PMID: 39454886 Free article.
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091).
Reijneveld JC, Machingura A, Coens C, Taphoorn MJB, Taal W, Clement PM, Idbaih A, de Vos FYF, Klein M, Wick W, Mulholland PJ, Lewis J, Golfinopoulos V, Ghislain I, Bottomley A, van den Bent MJ; EORTC Brain Tumor Group. Reijneveld JC, et al. Among authors: van den bent mj. Eur J Cancer. 2023 Sep;190:112946. doi: 10.1016/j.ejca.2023.112946. Epub 2023 Jun 19. Eur J Cancer. 2023. PMID: 37453240 Free article. Clinical Trial.
Impact of Novel Treatments in Patients with Melanoma Brain Metastasis: Real-World Data.
Derks SHAE, Jongen JLM, van der Meer EL, Ho LS, Slagter C, Joosse A, de Jonge MJA, Schouten JW, Oomen-de Hoop E, van den Bent MJ, van der Veldt AAM. Derks SHAE, et al. Among authors: van der meer el, van der veldt aam, van den bent mj. Cancers (Basel). 2023 Feb 25;15(5):1461. doi: 10.3390/cancers15051461. Cancers (Basel). 2023. PMID: 36900253 Free PMC article.
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0.
Albert NL, Preusser M, Traub-Weidinger T, Tolboom N, Law I, Palmer JD, Guedj E, Furtner J, Fraioli F, Huang RY, Johnson DR, Deroose CM, Herrmann K, Vogelbaum M, Chang S, Tonn JC, Weller M, Wen PY, van den Bent MJ, Verger A, Ivanidze J, Galldiks N. Albert NL, et al. Among authors: van den bent mj. Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3662-3679. doi: 10.1007/s00259-024-06783-x. Epub 2024 Jun 20. Eur J Nucl Med Mol Imaging. 2024. PMID: 38898354 Free PMC article.
551 results